Activity Stream
@moatrx
• one week ago
Posted a new blog:
US IGA NEPHROPATHY LAUNCH READINESS
US IGA NEPHROPATHY LAUNCH READINESS
eGFR-confirmed evidence, not a second accelerated approval on UPCR surrogate data, resolves payer caution in IgA nephropathy.
Budesonide (Tarpeyo, roughly 60%...



